COVID-19–related hospitalizations among Aotearoa, New Zealand children during the Omicron era of SARS-CoV-2

Taylor, A; Best, EJ; Walls, T; Webb, R; Bhally, H; Bryce, A; Chang, CL; Chen, K; Dummer, J; Epton, M; Good, W; Goodson, J; Grey, C; Grimwade, K; Hancox, RJ; Hassan, RZ; Hills, T; Hotu, S; McArthur, C; Morpeth, S; Murdoch, DR; Pease, F; Pylypchuk, R; Raymond, N; Ritchie, S; Ryan, D; Selak, V; Storer, M; Williman, J; Wong, C; Wright, K; Maze, MJ

COVID-19–related hospitalizations among Aotearoa, New Zealand children during the Omicron era of SARS-CoV-2

Taylor, A Best, EJ Walls, T Webb, R Bhally, H Bryce, A Chang, CL Chen, K Dummer, J Epton, M Good, W Goodson, J Grey, C Grimwade, K Hancox, RJ Hassan, RZ Hills, T Hotu, S McArthur, C Morpeth, S Murdoch, DR Pease, F Pylypchuk, R

Raymond, N Ritchie, S Ryan, D Selak, V Storer, M Williman, J Wong, C Wright, K Maze, MJ

Permalink

Publisher:: Elsevier
Publication Type:: Journal Article
Citation:: IJID Regions, 2024, 12, pp. 100408
Issue Date:: 2024-09-01

Open Access

Copyright Clearance Process

Recently Added
In Progress
Open Access

This item is open access.

Download Published versionAdobe PDF (455.54 kB)

View on publisher's site

View statistics

Full metadata record

Field	Value	Language
dc.contributor.author	Taylor, A
dc.contributor.author	Best, EJ
dc.contributor.author	Walls, T
dc.contributor.author	Webb, R
dc.contributor.author	Bhally, H
dc.contributor.author	Bryce, A
dc.contributor.author	Chang, CL
dc.contributor.author	Chen, K
dc.contributor.author	Dummer, J
dc.contributor.author	Epton, M
dc.contributor.author	Good, W
dc.contributor.author	Goodson, J
dc.contributor.author	Grey, C
dc.contributor.author	Grimwade, K
dc.contributor.author	Hancox, RJ
dc.contributor.author	Hassan, RZ
dc.contributor.author	Hills, T
dc.contributor.author	Hotu, S
dc.contributor.author	McArthur, C
dc.contributor.author	Morpeth, S
dc.contributor.author	Murdoch, DR
dc.contributor.author	Pease, F
dc.contributor.author	Pylypchuk, R https://orcid.org/0000-0002-8507-0467
dc.contributor.author	Raymond, N
dc.contributor.author	Ritchie, S
dc.contributor.author	Ryan, D
dc.contributor.author	Selak, V
dc.contributor.author	Storer, M
dc.contributor.author	Williman, J
dc.contributor.author	Wong, C
dc.contributor.author	Wright, K
dc.contributor.author	Maze, MJ
dc.date.accessioned	2024-10-10T00:48:35Z
dc.date.available	2024-10-10T00:48:35Z
dc.date.issued	2024-09-01
dc.identifier.citation	IJID Regions, 2024, 12, pp. 100408
dc.identifier.issn	2772-7076
dc.identifier.issn	2772-7076
dc.identifier.uri	http://hdl.handle.net/10453/181358
dc.description.abstract	Objectives: This multicenter cohort study describes Aotearoa New Zealand children hospitalized during the country's first wave of sustained SARS-CoV-2 transmission, Omicron variant. Methods: Children younger than 16 years, hospitalized for >6 hours with COVID-19 across New Zealand from January to May 2022 were included. Admissions for all Māori and Pacific and every second non-Maori non-Pacific children were selected to support equal explanatory power for ethnic grouping. Attribution of hospital admission, demography, clinical presentation, comorbidity, treatment, and outcome data were collected. Results: Of 444 hospitalizations of children positive for COVID-19, 292 (65.5%) from 290 children were considered admissions attributable to COVID-19. Of these admissions, 126 (43.4%) were aged under 1; 118 (40.7%), 99 (34.1%), and 87 (30.0%) were children of Māori, Pacific, and non-Maori non-Pacific ethnicity, respectively. Underlying respiratory disease was the most common comorbidity, present in 22 children (7.6%); 16 children (5.5%) were immunosuppressed. Median length of stay was 1 day (interquartile range 0.0-2.0). Four children received antiviral, 69 (24%) antibacterial, and 24 (8%) supplemental oxygen. Although eight children required intensive care, there were no deaths. Conclusions: Children hospitalized during the first significant wave of SARS-CoV-2 infection in New Zealand presented with a multi-system viral illness and rarely with severe disease.
dc.language	en
dc.publisher	Elsevier
dc.relation.ispartof	IJID Regions
dc.relation.isbasedon	10.1016/j.ijregi.2024.100408
dc.rights	info:eu-repo/semantics/openAccess
dc.title	COVID-19–related hospitalizations among Aotearoa, New Zealand children during the Omicron era of SARS-CoV-2
dc.type	Journal Article
utslib.citation.volume	12
pubs.organisational-group	University of Technology Sydney
pubs.organisational-group	University of Technology Sydney/Faculty of Health
pubs.organisational-group	University of Technology Sydney/UTS Groups
pubs.organisational-group	University of Technology Sydney/UTS Groups/Women & Children’s Health Research Collaborative (WCHC)
pubs.organisational-group	University of Technology Sydney/UTS Groups/INSIGHT: Institute for Innovative Solutions for Well-being and Health
utslib.copyright.status	open_access	*
dc.rights.license	This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0). To view a copy of this license, visit https://creativecommons.org/licenses/by-nc-nd/4.0/
dc.date.updated	2024-10-10T00:48:34Z
pubs.publication-status	Published
pubs.volume	12

Abstract:

Objectives: This multicenter cohort study describes Aotearoa New Zealand children hospitalized during the country's first wave of sustained SARS-CoV-2 transmission, Omicron variant. Methods: Children younger than 16 years, hospitalized for >6 hours with COVID-19 across New Zealand from January to May 2022 were included. Admissions for all Māori and Pacific and every second non-Maori non-Pacific children were selected to support equal explanatory power for ethnic grouping. Attribution of hospital admission, demography, clinical presentation, comorbidity, treatment, and outcome data were collected. Results: Of 444 hospitalizations of children positive for COVID-19, 292 (65.5%) from 290 children were considered admissions attributable to COVID-19. Of these admissions, 126 (43.4%) were aged under 1; 118 (40.7%), 99 (34.1%), and 87 (30.0%) were children of Māori, Pacific, and non-Maori non-Pacific ethnicity, respectively. Underlying respiratory disease was the most common comorbidity, present in 22 children (7.6%); 16 children (5.5%) were immunosuppressed. Median length of stay was 1 day (interquartile range 0.0-2.0). Four children received antiviral, 69 (24%) antibacterial, and 24 (8%) supplemental oxygen. Although eight children required intensive care, there were no deaths. Conclusions: Children hospitalized during the first significant wave of SARS-CoV-2 infection in New Zealand presented with a multi-system viral illness and rarely with severe disease.

Please use this identifier to cite or link to this item:

http://hdl.handle.net/10453/181358